Get started
Author

Hikmet Akar

Observed name: Hikmet AKAR
Observed institution: Manisa Celal Bayar University
ORCID: 0000-0001-7082-2542
Observed ORCID: 0000-0001-7082-2542
OpenAlex ID: A5113931212
SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer
2025 · Hikmet Akar, Ferhat Ekinci, et al. · Medicina · 3
PDF
Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group
2026 · Haydar Cagatay Yuksel, Elvina Almuradova, et al. · Frontiers in Oncology · 1
PDF
Cutaneous Anaplastic Large Cell Lymphoma with Dramatic Response to Brentuximab Vedotin
2020 · Mustafa Şahin, Mine Miskioglu, et al. · Turkish Journal of Hematology · 1
PDF
Case report of locally advanced basal cell carcinoma with complete response and long-term follow-up with vismodegib therapy
2026 · Hikmet Akar, Ferhat Ekinci, et al. · Polish Journal of Pathology
PDF
Efficacy of Immunotherapy at Progression in Durvalumab-Naïve Stage III Non-Small Cell Lung Cancer After Chemoradiotherapy: A Multicenter Retrospective Study of 403 Patients
2026 · Büşra Bülbül, Orhan Önder Eren, et al. · Preprints.org
Prognostic Value of the Prognostic Nutritional Index in Patients with Metastatic Melanoma
2026 · Mustafa Sahbazlar, Hikmet Akar, et al. · Journal of Cancer
PDF
Efficacy of Immunotherapy at Progression in Durvalumab-Naïve Stage III Non-Small Cell Lung Cancer After Chemoradiotherapy: A Multicenter Retrospective Study of 403 Patients
2026 · Büşra Bülbül, Orhan Önder Eren, et al. · Preprints.org
Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study
2026 · Anıl Karakayalı, Mustafa Seyyar, et al. · Medicina
Brucellosis with Neutropenia in an Immunocompetent Patient
2025 · Çağlar IRMAK, Cevdet Furkan KÖŞKER, et al. · Turkiye Klinikleri Journal of Case Reports
PDF
Works count: 9
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type